PATENT CLAIM ANALYSIS

Application Number: 15771077
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-12
Patent Classification: ["514", "237500"]

Abstract:
Described herein, inter alia, are compositions and methods for treating or preventing obesity and using the same.

Claim (Index 35):
The method of  claim 32 , wherein administering comprises oral administration, intravenous administration, topical administration, parenteral administration, intraperitoneal administration, intramuscular administration, intrathecal administration, intralesional administration, intracranial administration, intranasal administration, intraocular administration, intracardiac administration, intravitreal administration, intraosseous administration, intracerebral administration, intraarterial administration, intraarticular administration, intradermal administration, transdermal administration, transmucosal administration, sublingual administration, enteral administration, sublabial administration, insufflation administration, suppository administration, inhaled administration, or subcutaneous administration.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 91.0
- Lexical Diversity: 1.11111
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14679846', '14248787', '15263033', '15665755', '13141310']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7962815572642643
- 35 USC 102 Novelty (BERT): 0.527823882075463
- Combined Prediction Score: 0.7694357897453842
- Mean Citation Score: 301.98621799999995
- Max Citation Score: 317.74167
- Similarity Product: 175.52786348971188

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test